SAGE: A Segment-Anchor-Guided Exploration Framework for the Optimization of CDK7 Inhibitors as Promising Cancer Therapy
The Journal of Physical Chemistry B · 2025
DOI: 10.1021/acs.jpcb.5c02076 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2025. Verfasst von Zhaoqi Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Quantitative Biology, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinases, Protein Kinase Inhibitors, Antineoplastic Agents, Pyrimidines. Die Arbeit nennt 71 Literaturangaben. Gefördert von: Zhejiang University, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cyclin-dependent kinase 7 (CDK7) plays a crucial role in cell cycle regulation and transcription, establishing it as a promising target for cancer therapy. Although the covalent inhibitor THZ1 effectively targets CDK7, it presents risks such as a short half-life and potential off-target side effects. To address these limitations, we employed a computational workflow integrating virtual screening, molecular dynamics (MD) simulations, and the free energy perturbation (FEP) method to design noncovalent CDK7 inhibitors with enhanced selectivity and safety profiles. MD simulations elucidated THZ1's inhibitory mechanism and identified key molecular fragments within its structure. By incorporating fragments from known inhibitors, we introduced extensive noncovalent interactions within the binding pocket, leading to the identification of three novel noncovalent inhibitors with binding affinities comparable to or higher than that of THZ1. Our findings not only introduce promising CDK7 inhibitors but also present a robust computational framework that could accelerate the discovery of kinase-targeted therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Quantitative Biology, Zhejiang University, Hangzhou 310058, China.
- School of Physics, Zhejiang University, Hangzhou 310058, China.
- Shanghai Institute for Advanced Study, Zhejiang University, Shanghai 201203, China.
- Department of Chemistry, Columbia University, New York, New York 10027, United States.
ORCID-Profile: Ruhong Zhou
Förderung
- Zhejiang University
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanghai Artificial Intelligence Lab
- Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study
- National Center of Technology Innovation for Biopharmaceuticals
- National Independent Innovation Demonstration Zone Shanghai Zhangjiang Major Projects
Zitieren
APA
Shi, Z., Gao, X., Buratto, D., & Zhou, R. (2025). SAGE: A Segment-Anchor-Guided Exploration Framework for the Optimization of CDK7 Inhibitors as Promising Cancer Therapy. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.5c02076
Vancouver
Shi Z, Gao X, Buratto D, Zhou R. SAGE: A Segment-Anchor-Guided Exploration Framework for the Optimization of CDK7 Inhibitors as Promising Cancer Therapy. The Journal of Physical Chemistry B. 2025. doi:10.1021/acs.jpcb.5c02076
BibTeX
@article{Shi2025,
author = {Shi, Zhaoqi and Gao, Xufan and Buratto, Damiano and Zhou, Ruhong},
title = {SAGE: A Segment-Anchor-Guided Exploration Framework for the Optimization of CDK7 Inhibitors as Promising Cancer Therapy},
journal = {The Journal of Physical Chemistry B},
year = {2025},
doi = {10.1021/acs.jpcb.5c02076}
}
EUVIMED